Karnofsky Performance StatusBrain NeoplasmsSurvival AnalysisGlioblastomaTreatment OutcomeSupratentorial NeoplasmsPrognosisDacarbazineAntineoplastic Combined Chemotherapy ProtocolsSurvival RateCombined Modality TherapyRadiosurgeryDrug Administration ScheduleLung NeoplasmsRetrospective StudiesGliomaDeoxycytidineDisease-Free SurvivalAntineoplastic Agents, AlkylatingPalliative CareCranial IrradiationKaplan-Meier EstimateQuality of LifeCisplatinCarcinoma, Non-Small-Cell LungNeoplasm StagingAntineoplastic AgentsRadiotherapy DosageMultivariate AnalysisNeoplasm Recurrence, LocalProportional Hazards ModelsAntimetabolites, AntineoplasticNeoplasm MetastasisFollow-Up StudiesRadiotherapyNeoplasmsProspective StudiesFluorouracilKidney NeoplasmsRadiotherapy, AdjuvantCarcinoma, Renal CellTime FactorsAdenocarcinomaAstrocytomaCentral Nervous System NeoplasmsCarboplatinDose FractionationInfusions, IntravenousDisease ProgressionProcarbazineVinblastineEtoposideSalvage TherapyOligodendrogliomaCarmustineRemission InductionAge FactorsNeoplasm GradingAnalysis of VarianceMethotrexatePsychomotor PerformanceDNA Modification MethylasesNeurosurgical ProceduresLymphoma, Non-HodgkinTask Performance and AnalysisPredictive Value of TestsHealth StatusPancreatic NeoplasmsRisk FactorsQuestionnairesPaclitaxelNutritional StatusChemotherapy, AdjuvantSeverity of Illness IndexAdministration, OralCarcinoma, Small CellRecurrenceRegression AnalysisCohort StudiesMagnetic Resonance ImagingLymphomaDose-Response Relationship, DrugRisk AssessmentTumor Markers, BiologicalTaxoidsVincristineDoxorubicinFatigue